About empagliflo zin
Sodium-glucose cotransporter-2 inhibitor
Used for
- Type 2 diabetes, alongside diet and exercise
- Reducing cardiovascular death risk in adults with type 2 diabetes and heart disease
- Treating chronic heart failure
- Treating chronic kidney disease
Usual adult dose
Usually 10 mg once daily; may increase to 25 mg daily for blood sugar control.
Usual dose in children
For type 2 diabetes, 10 mg once daily from age 10; may increase to 25 mg daily.
Common side effects
- Genital yeast infections
- Urinary tract infections
- Increased urination
- Dehydration or low blood pressure
Important warnings
- Can rarely cause diabetic ketoacidosis, even when blood sugar is not very high.
- Risk of dehydration and kidney problems may increase during illness or poor fluid intake.
- Seek urgent assessment for severe genital or perineal pain, redness, or swelling with fever.
- Not used for type 1 diabetes; kidney function affects suitability and glucose-lowering effect.
Pregnancy
Not recommended, especially during the second and third trimesters; pregnancy safety is uncertain.
Breastfeeding
Not recommended because effects on a nursing infant are unknown and kidney development may be affected.
Interactions
- Insulin or sulfonylureas may increase low-blood-sugar risk.
- Diuretics may increase dehydration and low blood pressure.
- Lithium levels may be reduced.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.